| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +14.29% | +13.25% | +0.57% | +12.68% | +3.24% | — |
| 14d | 7 | +28.57% | +11.22% | -0.05% | +11.27% | +4.69% | — |
| 30d | 7 | +57.14% | -1.12% | +0.43% | -2.54% | -9.41% | — |
| 60d | 7 | +57.14% | -4.66% | +1.07% | -5.73% | -10.81% | — |
| 90d | 7 | +42.86% | -0.91% | -1.24% | -0.91% | -3.02% | — |
| 180d | 7(3 pending) | +0.00% | +20.03% | +8.08% | +11.95% | -4.01% | — |
| 1y | 7(7 pending) | — | — | — | — | — | — |
| 2y | 7(7 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE President & CEO | 9,500 | $23.18 | $220.2K | 585,038 | Jul 16, 2026 | Jul 17, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,998 | $19.41 | $97.0K | 595,006 | Jun 1, 2026 | Jun 2, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 468 | $19.73 | $9.2K | 594,538 | Jun 1, 2026 | Jun 2, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,467 | $18.92 | $103.4K | 600,004 | May 1, 2026 | May 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE President & CEO | 8,000 | $17.64 | $141.1K | 605,471 | Apr 14, 2026 | Apr 15, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,466 | $17.92 | $98.0K | 613,471 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,707 | $23.24 | $86.2K | 620,696 | Jan 7, 2026 | Jan 9, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 309 | $24.57 | $7.6K | 618,937 | Jan 7, 2026 | Jan 9, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,450 | $23.88 | $34.6K | 619,246 | Jan 7, 2026 | Jan 9, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE President & CEO | 10,135 | $15.17 | $153.7K | 624,403 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 406,000 | — | — | 406,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 634,538 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 128,000 | — | — | 544,538 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 575,000 | — | — | 575,000 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 346,000 | — | — | 346,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 472,000 | — | — | 472,000 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 315,600 | — | — | 315,600 | Mar 1, 2022 | Mar 2, 2022 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 141,623 | — | — | 141,623 | Jun 23, 2021 | Jun 25, 2021 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 538,517 | — | — | 538,517 | Apr 12, 2021 | Jun 25, 2021 ↗ | View → |